Ex vivo culture resting time impacts transplantation outcomes of genome-edited human hematopoietic stem and progenitor cells in xenograft mouse models
- 24 February 2024
- journal article
- research article
- Published by Elsevier in Cytotherapy
- Vol. 26 (6) , 641-648
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute
- Division of Intramural Research
- National Institutes of Health (R01HL120669)
This publication has 40 references indexed in Scilit:
- Pre-existing immunity does not impair the engraftment of CRISPR-Cas9-edited cells in rhesus macaques conditioned with busulfan or radiationMolecular Therapy - Methods & Clinical Development, 2023
- Sickle Cell DiseaseJAMA, 2022
- Engineered virus-like particles for efficient in vivo delivery of therapeutic proteinsCell, 2022
- Low-Dose Busulfan Reduces Human CD34+ Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient MiceMolecular Therapy - Methods & Clinical Development, 2019
- Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene TargetingMolecular Therapy Nucleic Acids, 2018
- Hematopoietic Stem Cell Transplantation in ThalassemiaHematology/Oncology Clinics of North America, 2018
- Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34 + Hematopoietic Stem and Progenitor CellsMolecular Therapy - Methods & Clinical Development, 2017
- Concise Reviews: A Stem Cell Apostasy: A Tale of Four H WordsStem Cells, 2014
- A Distinctive DNA Damage Response in Human Hematopoietic Stem Cells Reveals an Apoptosis-Independent Role for p53 in Self-RenewalCell Stem Cell, 2010
- Hematopoietic Stem Cell Quiescence Promotes Error-Prone DNA Repair and MutagenesisCell Stem Cell, 2010